What question did this study set out to answer?

The aim was to determine if platelet counts during pregnancy are higher in women later diagnosed with myeloproliferative neoplasms compared to controls.

July 1, 2026European Journal Of Haematology

Platelet Counts During Pregnancy as Predictor of Subsequent Myeloproliferative Neoplasm

View Full Paper

Ask AI

Bookmark

The aim was to determine if platelet counts during pregnancy are higher in women later diagnosed with myeloproliferative neoplasms compared to controls.
Nested case-control study conducted among pregnant women in Denmark from 2010 to 2017.
Used registry and laboratory data to analyze platelet counts during pregnancy.
Compared cases of MPN (N=49) to matched controls (N=979).
Cases had significantly higher platelet counts during pregnancy (325 vs. 219 ×10^9 /L, p=0.002).
29% of cases had platelet counts >400 compared to 2% of controls (p<0.001).
Platelet counts >400 were associated with an 18-fold increased odds ratio (95% CI: 6–61) for subsequent MPN.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Nested case-control study finds elevated platelet counts predict myeloproliferative neoplasm in women post-pregnancy, suggesting early monitoring benefits.

Cite This Study

Klok et al. (2026) studied this question.

synapsesocial.com/papers/6a44b0085cd2549c8bc44d2a https://doi.org/10.1111/ejh.70257

View Full Paper

Ask AI

Bookmark

Implication

Nested case-control study finds elevated platelet counts predict myeloproliferative neoplasm in women post-pregnancy, suggesting early monitoring benefits.

Platelet Counts During Pregnancy as Predictor of Subsequent Myeloproliferative Neoplasm

Key Points

Discussion

Implication

Cite This Study

Platelet Counts During Pregnancy as Predictor of Subsequent Myeloproliferative Neoplasm

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider